MRPL3 and pachyonychia congenita: In a clinical cohort of 142 patients with PC, IHC revealed that high MRPL3 expression was associated with significantly shorter OS (HR = 2.13, 95% CI = 1.35-3.34, p = 0.001) (Figure 7C).